Transitional Care Interventions for Patients With Cirrhosis Post-TIPS

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

76 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators conducted a randomized controlled trial to describe if multidisciplinary and patient-centered transitional care interventions for patients with cirrhosis post-TIPS can improve compliance behavior and reduce complications post-TIPS after discharge.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Impact of Transjugular Intrahepatic Portosystemic Shunt on Recompensation in Patients With Decompensated Liver Cirrhosis

NCT07172035

Cirrhosis Decompensation Transjugular Intrahepatic Portosystemic Shunt (TIPS) +1 more

RECRUITING

Incidence and Predictors of Post-TIPS Heart Failure in Patients With Cirrhosis

NCT05596253

Liver Cirrhosis Transjugular Intrahepatic Portosystemic Shunt (TIPS) Heart Failure

RECRUITING

Nurse Assisted Post-discharge Intervention in Decompensated Cirrhosis

NCT04158986

Liver Cirrhosis

COMPLETED NA

Transitional Care Program for Fluid Overload in Cirrhosis

NCT06174272

Cirrhosis, Liver

RECRUITING NA

Comparison of the Effect of Two Interventions on Liver Frailty Index in Pre-frail and Frail Cirrhotic Patients Enlisted for Liver Transplantation

NCT06149026

Cirrhosis, Liver

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fibrosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control group

The conventional care was performed for the patients of control group

Group Type NO_INTERVENTION

No interventions assigned to this group

Intervention group

the prevention of complications post-TIPS

Group Type EXPERIMENTAL

the prevention of complications post-TIPS

Intervention Type BEHAVIORAL

Continuous nursing through telephone follow-up, family visits, and WeChat guided patients to prevent gastrointestinal bleeding, infection and constipation ,intake quality low-protein diet, recognize minimal encephalopathy, monitor blood ammonia, return visit regularly, deal with adverse drug reactions of anticoagulant.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

the prevention of complications post-TIPS

Continuous nursing through telephone follow-up, family visits, and WeChat guided patients to prevent gastrointestinal bleeding, infection and constipation ,intake quality low-protein diet, recognize minimal encephalopathy, monitor blood ammonia, return visit regularly, deal with adverse drug reactions of anticoagulant.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clinical diagnosis of diagnosis of cirrhosis;
* Child-Pugh Score \<10;
* Informed Consent.

Exclusion Criteria

* Age \<18 years;
* Right ventricular failure;
* Severe systemic infection;
* Hepatocellular carcinoma (HCC);
* Terminal disease; and
* Failure to provide written consent to participate in the study.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No